Skip to content

AICAR (acadesine) studies: 330 papers with results

Page 3 of 7

  1. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.

    Vitzel KF · PloS one · 2013

    Animal study (in vivo) · rat · 6 results

  2. Post-treatment with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injury.

    Idrovo JP · Shock (Augusta, Ga.) · 2012

    Animal study (in vivo) · rat · 11 results

  3. Differential attenuation of AMPK activation during acute exercise following exercise training or AICAR treatment.

    McConell GK · Journal of applied physiology (Bethesda, Md. : 1985) · 2008

    Animal study (in vivo) · rat · 4 results

  4. Effects of chronic AICAR administration on the metabolic and contractile phenotypes of rat slow- and fast-twitch skeletal muscles.

    Bamford JA · Canadian journal of physiology and pharmacology · 2003

    Animal study (in vivo) · rat · 8 results

  5. SESN2 prevents the slow-to-fast myofiber shift in denervated atrophy via AMPK/PGC-1α pathway.

    Yang X · Cellular & molecular biology letters · 2022

    Animal study (in vivo) · mouse · 2 results

  6. Whether AICAR in Pregnancy or Lactation Prevents Hypertension Programmed by High Saturated Fat Diet: A Pilot Study.

    Tsai WL · Nutrients · 2020

    Animal study (in vivo) · rat · 9 results

  7. AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis.

    Bush ND · The Journal of pharmacology and experimental therapeutics · 2018

    Animal study (in vivo) · mouse · 8 results

  8. AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids.

    King-Himmelreich TS · Neuropharmacology · 2017

    Animal study (in vivo) · mouse · 1 result

  9. Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy.

    Chandrasekaran K · International journal of molecular sciences · 2024

    Animal study (in vivo) · mouse · 8 results

  10. AICAR Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the HGF/NF-κB/SNARK Signaling Pathway and Restores Mitochondrial and Endoplasmic Reticular Impairments in High-Fat Diet-Fed Rats.

    Zineldeen DH · International journal of molecular sciences · 2023

    Animal study (in vivo) · rat · 6 results

  11. AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice.

    Declèves AE · Journal of lipid research · 2019

    Animal study (in vivo) · mouse · 3 results

  12. Reductions in RIP140 are not required for exercise- and AICAR-mediated increases in skeletal muscle mitochondrial content.

    Frier BC · Journal of applied physiology (Bethesda, Md. : 1985) · 2011

    Animal study (in vivo) · rat · 6 results

  13. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.

    Zhang M · Bioscience reports · 2018

    Animal study (in vivo) · rat · 21 results

  14. Hypothalamic AMPK-induced autophagy ameliorates hypercatabolism in septic rats by regulating POMC expression.

    Cao C · Biochemical and biophysical research communications · 2018

    Animal study (in vivo) · rat · 3 results

  15. The AMPK Activator Aicar Ameliorates Age-Dependent Myocardial Injury in Murine Hemorrhagic Shock.

    Matsiukevich D · Shock (Augusta, Ga.) · 2017

    Animal study (in vivo) · mouse · 3 results

  16. Aerobic exercise suppresses CCN2 secretion from senescent muscle stem cells and boosts muscle regeneration in aged mice.

    Li F · Journal of cachexia, sarcopenia and muscle · 2024

    Animal study (in vivo) · mouse · 3 results

  17. Exogenous H2S alleviates senescence of glomerular mesangial cells through up-regulating mitophagy by activation of AMPK-ULK1-PINK1-parkin pathway in mice.

    E Y · Biochimica et biophysica acta. Molecular cell research · 2023

    Animal study (in vivo) · mouse · 27 results

  18. AMPK activation attenuates cancer-induced bone pain by reducing mitochondrial dysfunction-mediated neuroinflammation.

    Yang H · Acta biochimica et biophysica Sinica · 2023

    Animal study (in vivo) · rat · 5 results

  19. Activation of AMPKα2 Is Not Required for Mitochondrial FAT/CD36 Accumulation during Exercise.

    Monaco C · PloS one · 2015

    Animal study (in vivo) · 2 results

  20. AMPK activation ameliorates fine particulate matter-induced hepatic injury.

    Song L · Environmental science and pollution research international · 2020

    Animal study (in vivo) · mouse · 2 results

  21. Exercise Improves Outcomes of Surgery on Fatty Liver in Mice: A Novel Effect Mediated by the AMPK Pathway.

    Linecker M · Annals of surgery · 2020

    Animal study (in vivo) · mouse · 6 results

  22. Chronic activation of central AMPK attenuates glucose-stimulated insulin secretion and exacerbates hepatic insulin resistance in diabetic rats.

    Park S · Brain research bulletin · 2014

    Animal study (in vivo) · rat · 14 results

  23. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway.

    Bo C · BMC pulmonary medicine · 2024

    Animal study (in vivo) · rat · 2 results

  24. AICAR attenuates postoperative abdominal adhesion formation by inhibiting oxidative stress and promoting mesothelial cell repair.

    Wu Y · PloS one · 2022

    Animal study (in vivo) · rat · 14 results

  25. Estradiol regulates effects of hindbrain activator 5-aminoimidazole-4-carboxamide-riboside administration on hypothalamic adenosine 5'-monophosphate-activated protein kinase activity and metabolic neurotransmitter mRNA and protein expression.

    Alenazi FS · Journal of neuroscience research · 2015

    Animal study (in vivo) · rat · 15 results

  26. AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice.

    Tukhovskaya EA · International journal of molecular sciences · 2022

    Animal study (in vivo) · mouse · 6 results

  27. Central infusion of leptin does not increase AMPK signaling in skeletal muscle of sheep.

    Laker RC · American journal of physiology. Regulatory, integrative and comparative physiology · 2011

    Animal study (in vivo) · sheep · 1 result

  28. AMP-activated protein kinase activation prevents denervation-induced decline in gastrocnemius GLUT-4.

    Paulsen SR · Journal of applied physiology (Bethesda, Md. : 1985) · 2001

    Animal study (in vivo) · rat · 6 results

  29. Gypensapogenin I alleviates PANoptosis, ferroptosis, and oxidative stress in myocardial ischemic-reperfusion injury by targeting the NOX2/AMPK pathway.

    Chen Y · Frontiers in cell and developmental biology · 2025

    Animal study (in vivo) · mouse · 5 results

  30. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice.

    Zhou D · Innate immunity · 2015

    Animal study (in vivo) · mouse · 11 results

  31. Central administration of AICAR attenuates hypertension via AMPK/Nrf2 pathway in the hypothalamic paraventricular nucleus of hypertensive rats.

    Fu LY · European journal of pharmacology · 2024

    Animal study (in vivo) · rat · 11 results

  32. AMPK upregulates KCa2.3 channels and ameliorates endothelial dysfunction in diet-induced obese mice.

    Pang ZD · Biochemical pharmacology · 2021

    Animal study (in vivo) · mouse · 4 results

  33. Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder.

    Wang Z · Cardiovascular therapeutics · 2018

    Animal study (in vivo) · rat · 9 results

  34. The AMPK allosteric activator MK-8722 improves the histology and spliceopathy in myotonic dystrophy type 1 (DM1) skeletal muscle.

    Ravel-Chapuis A · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024

    Animal study (in vivo) · mouse · 5 results

  35. Akebia saponin D attenuates allergic airway inflammation through AMPK activation.

    Xuan L · Journal of natural medicines · 2024

    Animal study (in vivo) · mouse · 14 results

  36. Mitochondrial dysfunction in skeletal muscle of fukutin-deficient mice is resistant to exercise- and 5-aminoimidazole-4-carboxamide ribonucleotide-induced rescue.

    Southern WM · Experimental physiology · 2020

    Animal study (in vivo) · mouse · 2 results

  37. AICAR attenuates ischemia-reperfusion-induced AKI by modulating AMPK-TXNIP-NLRP3 pathway and energy metabolism.

    Gan L · Cellular and molecular life sciences : CMLS · 2026

    Animal study (in vivo) · rat · 20 results

  38. A comparison of chronic AICAR treatment-induced metabolic adaptations in red and white muscles of rats.

    Suwa M · The journal of physiological sciences : JPS · 2015

    Animal study (in vivo) · rat · 4 results

  39. Chronic treatment of old mice with AICAR reverses age-related changes in exercise performance and skeletal muscle gene expression.

    Wilcox SH · FASEB bioAdvances · 2025

    Animal study (in vivo) · mouse · 12 results

  40. AMPK activation improves depression-like symptoms in olfactory bulbectomized mice by regulating microglia M1/M2 polarization in the hippocampus.

    Odaira-Satoh T · Brain, behavior, & immunity - health · 2025

    Animal study (in vivo) · mouse · 6 results

  41. AMPK agonist AICAR ameliorates maternal hepatic lipid metabolism disorder, inflammation, and fibrosis caused by PM2.5 exposure during pregnancy.

    Wan T · Scientific reports · 2025

    Animal study (in vivo) · mouse · 3 results

  42. Exercise-induced Sesn2 mediates autophagic flux to alleviate neural damage after ischemic stroke in mice.

    Zhao Y · Experimental neurology · 2025

    Animal study (in vivo) · mouse · 4 results

  43. Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway.

    Fu LY · Cardiovascular toxicology · 2024

    Animal study (in vivo) · rat · 8 results

  44. Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.

    Paré MF · Frontiers in neurology · 2017

    Animal study (in vivo) · mouse · 6 results

  45. Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism.

    Baggott JE · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2007

    Animal study (in vivo) · rat · 1 result

  46. Brain AMPK signaling improves intestinal barrier function through brain orexin and the vagal pathway in rats.

    Funayama T · Neuroscience letters · 2025

    Animal study (in vivo) · rat · 10 results

  47. AMPK phosphorylation of KCa2.3 alleviates angiotensin II-induced endothelial dysfunction.

    Pang ZD · Biochemical pharmacology · 2025

    Animal study (in vivo) · mouse · 3 results

  48. 5-Aminoimidazole-4-carboxamide ribonucleotide prevents fat gain following the cessation of voluntary physical activity.

    Ruegsegger GN · Experimental physiology · 2017

    Animal study (in vivo) · rat · 8 results

  49. Loss of the anorexic response to systemic 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside administration despite reducing hypothalamic AMP-activated protein kinase phosphorylation in insulin-deficient rats.

    Vitzel KF · PloS one · 2013

    Animal study (in vivo) · rat · 13 results

  50. AMP-Activated Protein Kinase Treatment Ameliorates Chronic Restraint Stress Induced Memory Impairment in Early Adolescent Rat by Restoring Metabolite Profile and Synaptic Proteins.

    Rajan KE · Neurochemical research · 2024

    Animal study (in vivo) · rat · 2 results

How PepBank reports evidence